Tazemetostat: First Approval

This article summarizes the milestones in the development of tazemetostat leading to this first approval for the treatment of adults and adolescents aged ≥ 16 years with locally advanced or metastatic epithelioid sarcoma not eligible for complete resection.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research